← Back to Search

PRO Integration into Clinical Practice for Rheumatic Diseases

N/A
Waitlist Available
Led By Dinesh Khanna, MD, MSc
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial will test whether giving patients their PROMIS scores before appointments will help them better understand and manage their health.

Eligible Conditions
  • Rheumatic Diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Appointments at Which Patient-Reported Outcomes Measurement Information System (PROMIS) Scores Are Documented in the Electronic Medical Record (EMR) Note by the Participating Health Care Provider (HCP)
Secondary outcome measures
Change in Score of the Most Bothersome PROMIS Domain
Percent of Appointments at Which Referrals/Recommendations Related to PROMIS Scores Are Documented in the EMR Note by the Participating HCP
Quality of Patient-provider Communication

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PRO Integration into Clinical PracticeExperimental Treatment1 Intervention
PRO scores will be shared with patients and healthcare providers (HCPs) via an emailed report card
Group II: Usual CareActive Control1 Intervention
Patients and HCPs will not receive an emailed PROMIS score report. PROMIS scores, however, will be available in the EMR as usual.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRO Integration into Clinical Practice
2021
N/A
~110

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,810 Previous Clinical Trials
6,384,995 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
485 Previous Clinical Trials
1,086,799 Total Patients Enrolled
6 Trials studying Rheumatic Diseases
8,761 Patients Enrolled for Rheumatic Diseases
Dinesh Khanna, MD, MScPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
17 Total Patients Enrolled
~30 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top